MrK Trade

Veni, vidi, vici XLVII

MarKet Trade enthusiastic.

[The Long Investor @TheLongInvest]

What is one thing that the market knew was true but ignored it for the last few years?

I’ll start:

China’s Ai and Robotics capabilities are accelerating faster than expected and will outperform the US companies shortly.

The race is likely already lost

[MrK Trade @mrk_trade]

Spain is the clear favorite for the 2026 World Cup Final!Current odds:

Kalshi: Spain 58% | Argentina 42%(+$1.4M bet)

Bet365: Spain 1.85 | Argentina 4.00

DraftKings: Spain 1.83 | Argentina 4.10

FanDuel: Spain 1.87 | Argentina 3.95

#WorldCupFinal #SpainVsArgentina

[Kalshi @Kalshi]

BREAKING: Spain is the clear favorite to win the World Cup today

Current odds:
• Spain 58%
• Argentina 42%

[MrK Trade @mrk_trade]

$CLOV healthy pullback to the 50-day SMA.

Nothing has changed. The structure remains strongly bullish .

Primary Wave 3 target $8.48 📈 .

[Wall St Engine @wallstengine]

UNITEDHEALTH GROUP $UNH Q2’26 EARNINGS HIGHLIGHTS

🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY
🔹 Adj. EPS: $6.38 (Est. $4.85) 🟢; +56% YoY
🔹 MCR: 86.7% (Est. 88.6%) 🟢; -270 bps YoY
🔹 UnitedHealthcare OI: $3.9B; +86% YoY (Est. +40.7% YoY) 🟢

Raises FY26 Guide:
🔹 Adj. EPS: $19.50-$20.00 (Est ~$18.32) 🟢
🔹 EPS: $18.45-$18.95 (Prior: >$17.10)
🔹 Operating Earnings: >$25.45B (Prior: >$24.0B)
🔹 Net Earnings: >$16.75B (Prior: >$15.60B)
🔹 UnitedHealthcare Op. Earnings: >$12.0B (Prior: >$10.8B)
🔹 Optum Op. Earnings: >$13.45B (Prior: >$13.2B)
🔹 Medical Care Ratio: 88.1% ±25 bps (Prior: 88.8% ±50 bps)
🔹 Operating Cash Flow: ~$24.0B (Prior: >$18.0B)
🔹 Share Repurchases: ≥$5.0B (Prior: ~$2.5B)

Segment Net Revenue:
🔹 UnitedHealthcare: $86.0B; flat YoY
🔹 Optum: $65.7B; -2% YoY

Other Q2 Metrics:
🔹 Optum Op Income: $4.0B; +29% YoY (Est. +7.8% YoY) 🟢
🔹 Earnings from Operations: $8.0B; +54% YoY
🔹 Operating Cost Ratio: 12.7%; +40 bps YoY
🔹 Net Margin: 4.9%; +180 bps YoY
🔹 Cash Flows from Operations: $11.1B

Comments:
🔸 “Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people.”

[MrK Trade @mrk_trade]

$asts 58 down 11% after ,

market.

[MrK Trade @mrk_trade]

$ASTS is down -9.35% today and has broken below the 50-W SMA

We’re also seeing a clear weekly bearish divergence on the RSI

The 200-W SMA is sitting at $28.52

Sentiment around the stock has become extremely bullish, which often leads to pullbacks

Waiting for confirmation.

[MrK Trade @mrk_trade]

• If convertible note arbitrage forces a final sweep down, I’ll load more at $10-$10.50. 📉

• If the $11.80 support holds and we break key resistance, I’ll add on the breakout. 📈

Let the algos play, the fundamental narrative hasn't changed. #GorillaTechnology

[MrK Trade @mrk_trade]

Many of the biggest $GRRR bulls and promoters have gone completely silent on such a crucial day.

Been tracking this stock for a long time and finally made my 1st entry today.
Plan for the 2nd buy is simple:⬇️

[MrK Trade @mrk_trade]

$GRRR this money isn't to plug holes—it's to fund massive growth. The capital is strictly for the NeutraDC Batam data center project in Indonesia. Big risk, but huge asymmetric upside.

$2.5B deal is on the table .

[MrK Trade @mrk_trade]

$GRRR drops over 26% today, hitting the classic 0.78 Fib —perfect text-book target for a wave 2 correction in an ABC pattern. Driven by the second convertible notes news.

High risk, high reward, extreme volatility.

Did you take advantage of today's prices as well?

[MrK Trade @mrk_trade]

$PYPL Price just jumped 17%, breaking right through that key level after the news revealed Stripe’s $53B joint bid with Advent to buy PayPal.

Watching price action next to see if it holds above to confirm the breakout.

[MrK Trade @mrk_trade]

$PYPL Price is now heading toward a significant resistance area around $52–$53, where the descending 200SMA converges with horizontal supply.

This zone will be key. A break above could shift momentum higher, while a rejection may lead to further consolidation.

Gap to fill $50.

[Shay Boloor @StockSavvyShay]

Stripe and Advent International have offered to acquire $PYPL for $60.50 per share.

The bid is backed by roughly $50 billion in bank financing.

[Cantonese Cat 🐱🐈 @cantonmeow]

$SOFI now has close to 70% of institutional ownership.

[MrK Trade @mrk_trade]

$PYPL Price is now heading toward a significant resistance area around $52–$53, where the descending 200SMA converges with horizontal supply.

This zone will be key. A break above could shift momentum higher, while a rejection may lead to further consolidation.

Gap to fill $50.

[MrK Trade @mrk_trade]

$CELH insiders were buying the dip in late May.
Top execs stepped up to defend the $29 level:

CEO John Fieldly: $249K buy

Director Hal Kravitz: $250K buy

COO Eric Hanson: $218K buy

Total ~$716K in open-market purchases .

[*Walter Bloomberg @DeItaone]

TRUMP: THE MARKET IS GOING TO GO THROUGH THE ROOF

[MrK Trade @mrk_trade]

$CELH is waking up after a deep correction.

Price just broke above the 50-day SMA.

Major Wave 3 starting.

Primary target: $101.

[Ryan Detrick, CMT @RyanDetrick]

41 other times the S&P 500 gained more than 10% in a quarter.

The next quarter was higher 85% of the time.

The next two quarters were higher 85% of the time.

The next year was up a median of 13.4%.

Momentum is real.

[Prof @TheProfInvestor]

Healthcare is not the endgame. It's just Phase 1.

This is the rotation playbook for the next 18 months.

Most of you are looking at healthcare right now and wondering if it's too late.

It's not. Healthcare has been the most consistent sector in midterm election years for 30+ years. 80% win rate in the back half. That's the most reliable sector pattern in modern market history.

Here's what you need to know:

- 22 healthcare companies beat the S&P 500 in 75%+ of midterm years from 1994 to 2022.
- Zero of them underperformed.

But the real money isn't just in healthcare. It's in knowing WHEN to leave healthcare and where to go next.

The mistake most traders make is they ride healthcare all the way through 2027 and miss the bigger move.

- Year 3 of the presidential cycle is the strongest year in the entire 4-year cycle. Average return since 1933: +17.2%. Positive 90% of the time.

And it's NOT healthcare that leads Year 3. The leaders flip completely.

2026-2027 playbook:

Phase 1, July to November 2026: Heavy in healthcare. Add defense. Staples, utilities.

Phase 2, November to February 2027: Start trimming healthcare. Build tech and financials slowly.

Phase 3, February through end of 2027: Full risk on. Tech, financials, consumer discretionary lead the move.

Average gain from midterm year low to Year 3 high: +46.9%.

Healthcare names I'm watching: $LLY $UNH $ABBV $MRK $AMGN $TMO $DHR $SYK $DXCM $IDXX $HCA $PODD

ETFs to look at: $XBI $LABU $ARKG $GNOM

This is your roadmap.

[MrK Trade @mrk_trade]

$BABA is a BUY! The market is giving us a second chance before it shoots straight to $300.